financetom
Business
financetom
/
Business
/
Tyra Biosciences Names Doug Warner Chief Medical Officer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tyra Biosciences Names Doug Warner Chief Medical Officer
Sep 11, 2024 4:07 AM

04:47 PM EDT, 09/10/2024 (MT Newswires) -- Tyra Biosciences ( TYRA ) said late Tuesday that it has appointed Doug Warner as its chief medical officer.

The company said Warner held roles with increasing responsibility over 18 years at Amgen ( AMGN ) .

Most recently, Warner was chief medical officer for eFFECTOR Therapeutics.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Microsoft settles Caltech lawsuit over Wi-Fi technology
Microsoft settles Caltech lawsuit over Wi-Fi technology
Mar 13, 2024
* Caltech previously won billion-dollar verdict from Apple ( AAPL ), Broadcom ( AVGO ) in related case * University has ongoing cases against HP, Dell By Blake Brittain March 13 (Reuters) - Microsoft ( MSFT ) has agreed to settle a patent infringement lawsuit brought by the California Institute of Technology, which earlier won a billion-dollar jury verdict against...
UnitedHealth says its unit Change Healthcare's pharmacy network back online
UnitedHealth says its unit Change Healthcare's pharmacy network back online
Mar 13, 2024
March 13 (Reuters) - UnitedHealth Group ( UNH ) said on Wednesday that its unit Change Healthcare's pharmacy network was back online, weeks after the cyberattack on the unit. Change Healthcare processes about 50% of medical claims in the U.S. for around 900,000 physicians, 33,000 pharmacies, 5,500 hospitals and 600 laboratories. ...
US FDA approves expanded use of Mirum's liver disease drug
US FDA approves expanded use of Mirum's liver disease drug
Mar 13, 2024
March 13 (Reuters) - The U.S Food and Drug Administration has approved the expanded use of Mirum Pharmaceuticals' ( MIRM ) oral drug to treat itching caused by a liver disorder in patients aged five years and older, the company said on Wednesday. ...
Fossil CEO Leaves, Q4 Loss Widens, Sales Fall; Strategic Review Started -- Shares Up After Hours
Fossil CEO Leaves, Q4 Loss Widens, Sales Fall; Strategic Review Started -- Shares Up After Hours
Mar 13, 2024
06:07 PM EDT, 03/13/2024 (MT Newswires) -- Fossil Group ( FOSL ) said Wednesday Kosta N. Kartsotis stepped down as chief executive officer and a board member, effective immediately. Kartsotis will remain in a transitional role at the company until September and then work as a consultant through September 2025. The company selected Jeffrey N. Boyer, current chief operating officer,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved